Diversified Trust’s Provectus Biopharmaceuticals PVCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-50,000
Closed -$2K – 872
2022
Q3
$2K Hold
50,000
– – ﹤0.01% 766
2022
Q2
$3K Buy
+50,000
New +$3K ﹤0.01% 742

Other funds holding PVCT

Diversified Trust's PVCT Position: Q4 2022 in Review

Diversified Trust sold out of Provectus Biopharmaceuticals (PVCT) in Q4 2022, closing a stake of 50,000 shares — an estimated $2K sold.

Diversified Trust first reported a position in PVCT in Q2 2022 and held it in 2 quarters. The position peaked at $3K in Q2 2022. 7 funds tracked by Wall St. Rank hold PVCT as of Q4 2022.

  • Diversified Trust reported no remaining Provectus Biopharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Diversified Trust sold 50,000 Provectus Biopharmaceuticals shares in Q4 2022, an estimated $2K.
  • Diversified Trust first reported a position in Provectus Biopharmaceuticals in Q2 2022 and held it in 2 quarters.
  • Diversified Trust's Provectus Biopharmaceuticals position peaked at $3K in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Provectus Biopharmaceuticals as of Q4 2022.

Based on Diversified Trust's 13F filing for Q4 2022, filed 17 Jan 2023.